IL247025A0 - Enzyme inhibitors - Google Patents

Enzyme inhibitors

Info

Publication number
IL247025A0
IL247025A0 IL247025A IL24702516A IL247025A0 IL 247025 A0 IL247025 A0 IL 247025A0 IL 247025 A IL247025 A IL 247025A IL 24702516 A IL24702516 A IL 24702516A IL 247025 A0 IL247025 A0 IL 247025A0
Authority
IL
Israel
Prior art keywords
enzyme inhibitors
inhibitors
enzyme
Prior art date
Application number
IL247025A
Other languages
Hebrew (he)
Inventor
Brik Ashraf
Ohayon Shimrit
Gopinath Pushparathinam
Original Assignee
Technion Res & Dev Foundation
Brik Ashraf
Ohayon Shimrit
Gopinath Pushparathinam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technion Res & Dev Foundation, Brik Ashraf, Ohayon Shimrit, Gopinath Pushparathinam filed Critical Technion Res & Dev Foundation
Priority to IL247025A priority Critical patent/IL247025A0/en
Publication of IL247025A0 publication Critical patent/IL247025A0/en
Priority to PCT/IL2017/050839 priority patent/WO2018025259A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/02—Preparation of compounds containing amino groups bound to a carbon skeleton by substitution of hydrogen atoms by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/30—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reactions not involving the formation of esterified sulfo groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00—Preparation of quinones
    • C07C46/02—Preparation of quinones by oxidation giving rise to quinoid structures
    • C07C46/04—Preparation of quinones by oxidation giving rise to quinoid structures of unsubstituted ring carbon atoms in six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/32—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
IL247025A 2016-07-31 2016-07-31 Enzyme inhibitors IL247025A0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IL247025A IL247025A0 (en) 2016-07-31 2016-07-31 Enzyme inhibitors
PCT/IL2017/050839 WO2018025259A1 (en) 2016-07-31 2017-07-27 Enzyme inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL247025A IL247025A0 (en) 2016-07-31 2016-07-31 Enzyme inhibitors

Publications (1)

Publication Number Publication Date
IL247025A0 true IL247025A0 (en) 2016-09-29

Family

ID=61073514

Family Applications (1)

Application Number Title Priority Date Filing Date
IL247025A IL247025A0 (en) 2016-07-31 2016-07-31 Enzyme inhibitors

Country Status (2)

Country Link
IL (1) IL247025A0 (en)
WO (1) WO2018025259A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113087833B (en) * 2021-03-31 2022-04-01 湖北大学 Polymer-supported artificial catalysis triad catalyst and preparation method and application thereof
CN115403451B (en) * 2022-09-20 2024-01-19 阜阳欣奕华制药科技有限公司 Preparation method and application of 4-methoxy-2-naphthol

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3926747A1 (en) * 1989-08-12 1991-02-14 Basf Ag Fungicides containing 1,2-naphthoquinones
JPH09241104A (en) * 1996-03-07 1997-09-16 Kagome Co Ltd Antimicrobial agent containing naphthoquinone derivative as effective component
JP5339041B2 (en) * 2008-08-25 2013-11-13 学校法人武庫川学院 Novel naphthoquinone compounds and their pharmaceutical uses

Also Published As

Publication number Publication date
WO2018025259A1 (en) 2018-02-08

Similar Documents

Publication Publication Date Title
IL287113A (en) Smyd inhibitors
GB201421083D0 (en) Enzyme inhibitors
GB201421088D0 (en) New enzyme inhibitors
EP3160477A4 (en) Prmt5 inhibitors and uses thereof
EP3160466A4 (en) Prmt5 inhibitors and uses thereof
EP3177288A4 (en) Prmt5 inhibitors and uses thereof
IL269196A (en) Novel inhibitors
EP3116503A4 (en) Hptp-beta inhibitors
IL248895A0 (en) Phosphatidylinositol -kinase inhibitors
GB201416446D0 (en) New enzyme inhibitor compounds
GB201421085D0 (en) New enzyme inhibitors
EP3303324A4 (en) Novel corrosion inhibitors
IL265139B (en) Dopamine-b-hydroxylase inhibitors
ZA201907136B (en) Ip6k inhibitors
GB201612860D0 (en) Inhibitors
GB201501004D0 (en) Inhibitors
HK1251572A1 (en) Triaza-spirodecanones as ddr1 inhibitors
EP3148971A4 (en) Deubiquitinase inhibitors
HK1244790A1 (en) Bace1 inhibitors
IL274550A (en) Dopamine-b-hydroxylase inhibitors
EP3525786A4 (en) Kdm5 inhibitors
IL247025A0 (en) Enzyme inhibitors
PL3322724T3 (en) Il-26 inhibitors
GB201520949D0 (en) Inhibitors
EP3180003A4 (en) Pkc-epsilon inhibitors